Press Release OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference Jul 21
Press Release OKYO Pharma Announces Filing of Annual Report with Strengthened Cash Position and Accelerated Phase 3 Plans Jul 20
Press Release OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain Jul 8